J H Scholefield

10.7k total citations · 1 hit paper
172 papers, 7.2k citations indexed

About

J H Scholefield is a scholar working on Surgery, Oncology and Rheumatology. According to data from OpenAlex, J H Scholefield has authored 172 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Surgery, 72 papers in Oncology and 37 papers in Rheumatology. Recurrent topics in J H Scholefield's work include Anorectal Disease Treatments and Outcomes (50 papers), Colorectal Cancer Surgical Treatments (44 papers) and Colorectal and Anal Carcinomas (42 papers). J H Scholefield is often cited by papers focused on Anorectal Disease Treatments and Outcomes (50 papers), Colorectal Cancer Surgical Treatments (44 papers) and Colorectal and Anal Carcinomas (42 papers). J H Scholefield collaborates with scholars based in United Kingdom, United States and Canada. J H Scholefield's co-authors include Jonathan N. Lund, Nicholas FS Watson, Lindy G. Durrant, John Simpson, R. Steele, Austin G. Acheson, Robert E. Spiller, Keith Neal, K Rogers and S R Cairns and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

J H Scholefield

167 papers receiving 6.9k citations

Hit Papers

Guidelines for colorectal cancer screening and surveillan... 2010 2026 2015 2020 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J H Scholefield United Kingdom 44 4.1k 3.5k 1.4k 1.3k 1.1k 172 7.2k
Maria De Santis Italy 46 6.2k 1.5× 2.5k 0.7× 983 0.7× 1.1k 0.8× 2.2k 1.9× 217 10.2k
John M. Skibber United States 60 6.4k 1.6× 8.7k 2.5× 579 0.4× 655 0.5× 2.7k 2.4× 183 12.0k
Gary D. Steinberg United States 52 5.4k 1.3× 1.8k 0.5× 805 0.6× 443 0.3× 3.2k 2.7× 295 9.2k
Fabio Falcini Italy 38 836 0.2× 2.4k 0.7× 698 0.5× 835 0.6× 962 0.8× 261 5.4k
Ludovico Muzii Italy 49 2.4k 0.6× 981 0.3× 780 0.6× 818 0.6× 413 0.4× 352 7.9k
Mitchell C. Posner United States 43 2.3k 0.6× 2.9k 0.8× 284 0.2× 621 0.5× 2.5k 2.2× 175 6.4k
Howard A. Liebman United States 47 1.4k 0.4× 1.0k 0.3× 303 0.2× 911 0.7× 933 0.8× 157 9.9k
Mark L. Bernstein United States 48 1.1k 0.3× 1.8k 0.5× 905 0.7× 443 0.3× 2.7k 2.4× 184 7.5k
Pramod C. Sogani United States 49 6.2k 1.5× 1.4k 0.4× 887 0.6× 561 0.4× 2.3k 2.0× 114 7.9k
Guido Dalbagni United States 63 12.7k 3.1× 3.1k 0.9× 491 0.4× 804 0.6× 2.6k 2.3× 276 15.3k

Countries citing papers authored by J H Scholefield

Since Specialization
Citations

This map shows the geographic impact of J H Scholefield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J H Scholefield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J H Scholefield more than expected).

Fields of papers citing papers by J H Scholefield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J H Scholefield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J H Scholefield. The network helps show where J H Scholefield may publish in the future.

Co-authorship network of co-authors of J H Scholefield

This figure shows the co-authorship network connecting the top 25 collaborators of J H Scholefield. A scholar is included among the top collaborators of J H Scholefield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J H Scholefield. J H Scholefield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jayne, David, J H Scholefield, Damian Tolan, et al.. (2019). Anal fistula plug versus surgeon’s preference for surgery for trans-sphincteric anal fistula: the FIAT RCT. Health Technology Assessment. 23(21). 1–76. 24 indexed citations
3.
Negm, Ola H., Robert E. Schoen, Richard L. Whelan, et al.. (2016). Human Blood Autoantibodies in the Detection of Colorectal Cancer. PLoS ONE. 11(7). e0156971–e0156971. 23 indexed citations
4.
Acheson, Austin G., et al.. (2013). Results of laparoscopic colorectal surgery from a national training center. Asian Journal of Surgery. 37(1). 1–7. 1 indexed citations
5.
Humes, David J., Klara Garsed, Ching Lam, et al.. (2012). OC-119 Mechanistic randomised control trial of mesalazine in symptomatic diverticular disease: Abstract OC-119 Table 1. Gut. 61(Suppl 2). A51.3–A52. 13 indexed citations
6.
Whynes, David K., C M Mangham, T.W. Balfour, & J H Scholefield. (2010). Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer. Gut. 59(8). 1088–1093. 8 indexed citations
7.
Simpson, John, F. Sundler, David J. Humes, et al.. (2009). Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms. Neurogastroenterology & Motility. 21(8). 847–847. 98 indexed citations
8.
Simpson, John & J H Scholefield. (2008). Acute appendicitis. Surgery (Oxford). 26(3). 108–112. 3 indexed citations
9.
Nisar, Pasha J., Austin G. Acheson, Keith Neal, & J H Scholefield. (2004). Stapled Hemorrhoidopexy Compared With Conventional Hemorrhoidectomy: Systematic Review of Randomized, Controlled Trials. Diseases of the Colon & Rectum. 47(11). 1837–1845. 183 indexed citations
10.
Simpson, John, Dileep N. Lobo, Robert E. Spiller, & J H Scholefield. (2003). Diverticular Abscess of the Appendix. Diseases of the Colon & Rectum. 46(6). 832–834. 15 indexed citations
11.
Macafee, David, Charles Maxwell‐Armstrong, & J H Scholefield. (2003). Laparoscopic colorectal cancer surgery. Expert Review of Anticancer Therapy. 3(4). 484–492. 2 indexed citations
12.
Simpson, John, Keith Neal, J H Scholefield, & Robert E. Spiller. (2003). Patterns of pain in diverticular disease and the influence of acute diverticulitis. European Journal of Gastroenterology & Hepatology. 15(9). 1005–1010. 87 indexed citations
13.
Bramhall, Simon R., M T Hallissey, J Whiting, et al.. (2002). Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial. British Journal of Cancer. 86(12). 1864–1870. 199 indexed citations
14.
Scholefield, J H & R. Steele. (2002). Guidelines for follow up after resection of colorectal cancer. Gut. 51(suppl 5). v3–v5. 69 indexed citations
15.
Cairns, S R & J H Scholefield. (2002). Guidelines for colorectal cancer screening in high risk groups. Gut. 51(suppl 5). v1–v2. 47 indexed citations
17.
Robinson, M.H., J D Hardcastle, Sue Moss, et al.. (1999). The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut. 45(4). 588–592. 81 indexed citations
18.
Scholefield, J H, A G Johnson, & A. J. Shorthouse. (1998). Current surgical practice in screening for colorectal cancer based on family history criteria. British journal of surgery. 85(11). 1543–1546. 9 indexed citations
19.
Lund, Jonathan N., Deborah H. Bennett, Charles Maxwell‐Armstrong, et al.. (1998). A randomised trial of hospital versus home administered enemas for flexible sigmoidoscopy. BMJ. 317(7167). 1201–1210. 5 indexed citations
20.
Scholefield, J H, et al.. (1996). The aetiological significance of human papillomavirus in bladder cancer. British Journal of Urology. 78(6). 866–869. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026